Fatigue Completed Phase 2 Trials for Dalfampridine (DB06637)

Also known as: Exhaustion / Lethargy / Tiredness / Fatigue and tiredness / Worn out / Exhaustion (finding) / Washed-out / Other fatigue / Lethargy (finding) / Lethargic / Fatigue (finding) / Loss of energy / Energy decreased / Feeling of total lack of energy / Tired out / Fatigue extreme / Weariness / Lack of energy (finding)

IndicationStatusPhase
DBCOND0012333 (Fatigue)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02391961Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple SclerosisBasic Science
NCT01444300Dalfampridine for Imbalance in Multiple SclerosisTreatment